deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04616846

Thromboembolic Risk Screening in Patients With Cancer and COVID-19 (NEOTHROCOVID)

Sponsor: Centre Antoine Lacassagne

Conditions Covid19 Neoplasms Malignant Thromboembolism
Interventions Peripheral venous ultrasound
Updated 7 times since 2020 Last updated: Mar 8, 2022 Started: Aug 4, 2020 Primary completion: Jan 25, 2022 Completion: Jan 25, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04616846, this NA trial focuses on Covid19 and Neoplasms Malignant and remains completed. Sponsored by Centre Antoine Lacassagne, it has been updated 7 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotRecruiting~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshotRecruiting~Jan 2022 – ~Apr 2022 · 3 months · monthly snapshotRecruiting~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Apr 2022 — Jul 2024 [monthly]

    Completed NA

    Status: Recruiting → Completed

  4. Jan 2022 — Apr 2022 [monthly]

    Recruiting NA

  5. Dec 2021 — Jan 2022 [monthly]

    Recruiting NA

▶ Show 2 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Recruiting NA

  2. Dec 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Antoine Lacassagne
Data source: Centre Antoine Lacassagne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations